Detailed Narrative
Q1 FY26 Financial Performance Overview
Ion Exchange reported an operating income of INR 583.2 crores for Q1 FY26, marking a 3% year-on-year increase. Despite this, EBITDA saw a 2% decline to INR 62.7 crores, with the EBITDA margin standing at 10.75%. Net profit, however, increased by 8% year-on-year to INR 48.4 crores, achieving a PAT margin of approximately 8.3%.
Impact of SAP Migration on Q1 Operations
The company's migration to a new SAP platform in Q1 FY26 presented transition-related challenges, which partly impacted business volumes. The chemical business was particularly affected in April, leading to some unrecoverable revenue loss. For the engineering division, the impact was more of a timing issue, with recovery anticipated within the next two to three months of the current quarter and the first month of the next quarter, as operations have largely stabilized.
Segmental Performance Analysis
The Engineering division's revenue decreased by 2% YoY to INR 318 crores, but its EBIT surged by 48% YoY to INR 27.8 crores, partly due to a one-time📎 extra cost rebate. The Chemical division experienced a 5% YoY revenue reduction to INR 188.9 crores, with EBIT down 6% YoY to INR 46.7 crores, though it maintained its margin profile. The Consumer Product division demonstrated strong growth, with revenue increasing by 36% YoY to INR 90.2 crores, significantly reducing its loss from INR 3.4 crores to INR 0.9 crores.
Order Book and Bid Pipeline Status
As of the end of Q1 FY26, the total order book stood at INR 2664 crores, complemented by a robust bid pipeline exceeding INR 9200 crores. However, the engineering division faced delays in the finalization of certain large value opportunities, which impacted both order inflow and backlog. The execution of the UP Jal Nigam order remained muted, contributing to these challenges.
Roha Greenfield Plant Commissioning and Strategy
The greenfield manufacturing plant at Roha, involving a CAPEX of INR 400 crores (with INR 275 crores for the manufacturing base and INR 125 crores for cost optimization), is on track for commissioning in Q2 FY26. This plant is primarily designed to cater to the company's export markets across the Americas, Europe, Asia-Pacific, and the Middle East, with full capacity utilization expected over the next three to four years.
Challenges with UP Jal Nigam Project
The UP Jal Nigam project continues to be a point of concern due to very slow fund inflow from the government, leading to elevated accounts receivables and muted execution. The company has taken a conservative approach by reducing its estimate in the order backlog for this project. Management remains hopeful for an improvement in fund flow in the coming months, which would facilitate liquidation of receivables and ramp up execution.
Employee Trust Shareholding Clarification
Management clarified that 16.18% of the company's equity is held by an employee trust, which has been in existence since the 1980s and 90s. These shares are held for the benefit of all employees, and there are no current plans to dilute this equity. The income generated from these shares, primarily dividends, is utilized for employee benefits.